BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○
BiohacksAI/Targets/MAPK11/Compounds

Compounds That Target MAPK11

mitogen-activated protein kinase 11 · 145 compounds in BiohacksAI corpus

MAPK11 (mitogen-activated protein kinase 11) is a biological target with 145 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into MAPK11 modulation for therapeutic and biohacking applications.

View MAPK11 target page →UniProt: Q15759 ↗
Most Studied Compounds for MAPK11
1
Sorafenib
300+
studies
2
Isorhamnetin
300+
studies
3
Withaferin A
300+
studies
4
Dasatinib
299+
studies
5
Afatinib
297+
studies
6
Anisomycin
247+
studies
All 27 Compounds — Ranked by Evidence
1
Sb 203580
4.92
confidence
2
Foretinib
4.34
confidence
3
Ponatinib
4.26
confidence
4
Nilotinib
4.17
confidence
5
Doramapimod
4.06
confidence
6
Sb 202190
3.64
confidence
7
Regorafenib
3.56
confidence
8
Linifanib
3.33
confidence
9
Neflamapimod
3.30
confidence
10
Kw 2449
2.64
confidence
11
Linsitinib
2.64
confidence
12
Ast 487
2.56
confidence
13
Ph 797804
2.30
confidence
14
Rebastinib
2.20
confidence
15
Sorafenib
300+
studies
2.08
confidence
16
Skepinone L
2.08
confidence
17
Cep 32496
1.95
confidence
18
Bafetinib
1.95
confidence
19
Talmapimod
1.95
confidence
20
Bms 582949
1.95
confidence
21
Losmapimod
1.79
confidence
22
Tak 715
1.79
confidence
23
Afatinib
297+
studies
0.69
confidence
24
Anisomycin
247+
studies
0.69
confidence
25
Dasatinib
299+
studies
0.69
confidence
26
Isorhamnetin
300+
studies
0.69
confidence
27
Withaferin A
300+
studies
0.69
confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for MAPK11 (mitogen-activated protein kinase 11). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: MAPK11 target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.